What is the approach to cardiac risk assessment in an adult patient with a history of cardiovascular disease or risk factors undergoing non-cardiac surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardiac Risk Assessment in Noncardiac Surgery

Immediate Assessment: Identify Active Cardiac Conditions

First, determine if active cardiac conditions are present that mandate intensive management and may require delay or cancellation of elective surgery. These conditions include unstable coronary syndromes, unstable or severe angina, recent MI (within 30 days), decompensated heart failure, significant arrhythmias, and severe valvular disease 1. If any of these are present, surgery should be postponed unless emergent 1.

Step-by-Step Risk Stratification Algorithm

Step 1: Assess Surgical Risk

Categorize the planned surgery by 30-day cardiac event rate 1:

  • Low-risk surgery (<1% cardiac event rate): Endoscopic procedures, superficial procedures, cataract surgery, breast surgery, ambulatory surgery 1. These patients can proceed directly to surgery without further cardiac testing 1.

  • Intermediate-risk surgery (1-5% cardiac event rate): Intraperitoneal and intrathoracic surgery, carotid endarterectomy, head and neck surgery, orthopedic surgery, prostate surgery 1.

  • High-risk surgery (>5% cardiac event rate): Aortic and major vascular surgery, peripheral vascular surgery 1.

Step 2: Calculate Clinical Risk Using the Revised Cardiac Risk Index (RCRI)

The RCRI is the ACC/AHA-endorsed primary risk stratification tool and should be calculated for all patients. 2 Assign one point for each of the following six factors 1, 2:

  • History of ischemic heart disease (prior MI, positive stress test, current angina, pathologic Q waves on ECG)
  • History of compensated or prior heart failure
  • History of cerebrovascular disease (stroke or TIA)
  • Diabetes mellitus requiring insulin therapy
  • Chronic renal insufficiency (creatinine >2 mg/dL)
  • High-risk surgery (as defined above)

Risk stratification by RCRI score 2:

  • 0-1 points: Low risk (<1% major adverse cardiac events)
  • 2 points: Moderate risk
  • ≥3 points: High risk

Step 3: Assess Functional Capacity

Functional capacity is a critical determinant—patients who can climb 2 flights of stairs or achieve ≥4 METs during normal daily activities can generally proceed to surgery without further cardiac testing, even with known cardiovascular disease. 1, 3, 4, 5

Functional capacity categories 1:

  • Poor (<4 METs): Cannot walk 1-2 blocks on level ground or climb 1 flight of stairs
  • Moderate (4-10 METs): Can climb stairs, do heavy housework, play golf or doubles tennis
  • Excellent (>10 METs): Can participate in strenuous sports like swimming, singles tennis, or skiing

If functional capacity is ≥4 METs and the patient is asymptomatic, proceed to surgery regardless of clinical risk factors 1, 4.

Step 4: Determine Need for Further Testing

For patients with poor functional capacity (<4 METs), symptomatic status, or unknown functional capacity 1, 4:

  • 0-1 clinical risk factors: Proceed to surgery without further testing 1, 4

  • 2 clinical risk factors: Either proceed to surgery with beta-blocker therapy OR consider noninvasive stress testing only if results would change management 1, 4

  • ≥3 clinical risk factors undergoing vascular surgery: Consider noninvasive testing only if it will change management 1. Note that RCRI performs poorly in vascular surgery populations; consider using the NSQIP calculator instead 2.

  • ≥3 clinical risk factors undergoing intermediate-risk surgery: Insufficient data exist to determine optimal strategy; consider proceeding with tight heart rate control or testing if it will change management 1

Essential Preoperative Testing

Baseline Studies

  • 12-lead ECG: Obtain for patients with recent chest pain or ischemic symptoms undergoing intermediate- or high-risk surgery, asymptomatic patients with diabetes mellitus, and patients with cardiovascular risk factors undergoing intermediate- or high-risk procedures 1, 2, 3

  • Complete blood count: Order for patients with diseases increasing anemia risk (liver disease, hematologic disorders, chronic kidney disease) or when significant blood loss is anticipated, as hematocrit <28% increases perioperative ischemia risk 1, 3

  • Electrolytes and creatinine: Obtain for patients with chronic kidney disease, hypertension, heart failure, complicated diabetes, liver disease, or those taking diuretics, ACE inhibitors, ARBs, NSAIDs, or digoxin 3

Advanced Risk Assessment

For patients with RCRI ≥2, measuring preoperative NT-proBNP and/or troponin enhances risk prediction, improving discrimination by a median delta c-statistic of 0.12 over RCRI alone. 2 Consider troponin testing both preoperatively and 48-72 hours postoperatively in high-risk patients 1, 3.

The NSQIP Surgical Risk Calculator may offer superior discrimination compared to RCRI (median delta c-statistic 0.11 higher), particularly for procedure-specific risk assessment. 2

Cardiac Imaging

  • Resting echocardiography: Obtain for patients with current or poorly controlled heart failure, and consider for patients with prior heart failure or dyspnea of unknown origin 1, 3

  • Stress testing: Reserve for patients at higher risk with poor functional capacity (<4 METs) undergoing high-risk surgery, and only if results would change perioperative medical, anesthesia, or surgical approaches 1, 4, 5. Routine stress testing is not predictive and should not be performed routinely 4.

Critical Pitfalls to Avoid

  • Do not perform routine coronary revascularization before noncardiac surgery solely to reduce perioperative cardiac events—it does not reduce risk and should only be done for independent cardiac indications like unstable angina 4, 5

  • Emergency surgery patients should proceed immediately—focus on perioperative medical optimization rather than extensive testing, as consequences of delay outweigh benefits 2

  • Elective surgery must be delayed if dual antiplatelet therapy cannot be continued: 14 days after balloon angioplasty, 30 days after bare-metal stent, and optimally 365 days after drug-eluting stent 4

  • Age is an independent risk factor: Patients 66-85 years have OR 2.67 for delirium, and those >85 years have OR 6.24 compared to patients ≤65 years 2

  • Male sex independently increases risk (OR 1.28) and BMI <18.5 substantially increases delirium risk (OR 2.25) 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preoperative Evaluation Scoring Guides

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Preoperative Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Perioperative Risk Assessment and Management for Patients with Right Coronary Artery Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the approach to preoperative cardiovascular diagnostic testing for patients undergoing non-cardiac surgery?
What is the evidence for preoperative cardiac stress testing in patients prior to surgery?
Does a patient with no cardiovascular history and poor R (electrocardiogram) wave progression on EKG (electrocardiogram) require further cardiac testing prior to noncardiac surgery?
What laboratory tests, including proBNP (pro-brain natriuretic peptide), are recommended for patients undergoing noncardiac surgery, particularly those with a history of cardiovascular disease, and when should they be ordered?
When is cardiology involved in preoperative clearance versus primary care?
What is the recommended daily dose of Adderall (amphetamine and dextroamphetamine) for an adult patient with Attention Deficit Hyperactivity Disorder (ADHD)?
Will I completely recover from my nerve injury if I continue to use my arm as naturally as possible?
What is the typical effective dose range of Adderall (amphetamine and dextroamphetamine) for adult patients with Attention Deficit Hyperactivity Disorder (ADHD) who are not adequately managed at 20-30 mg tablets?
How to correct hypocalcemia with an ionized calcium level of 1.07 mmol/L?
Is 15 mg twice daily (bid) of Adderall (amphetamine and dextroamphetamine) a typical effective dose for an adult patient with Attention Deficit Hyperactivity Disorder (ADHD)?
Why is recovery from a partial nerve injury at the deltoid muscle level, with retained involuntary finger extension and flexion, so prolonged?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.